WT-1 A1

CAT: 0013-GTR19036653-01Size: 100 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19036653-01Size:100 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

WT-1 A1 is a promising immunotherapeutic target for pancreatic cancer research. This small molecule inhibitor facilitates the study of WT-1-driven oncogenesis and is utilized in both in vitro cell-based assays and in vivo preclinical models to evaluate potential therapeutic strategies.

Field of Research

Cancer Biology

Molecular Weight

1115.3

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19221534-01	WT-TTR inhibitor 1
GTR19261908-01	EGFR WT/T790M-IN-1
GTR19262468-01	EGFR WT/T790M/L858R-IN-1
GTR19061642-01	Wt hMLN
GTR19167659-01	WT-161
GTR19164309-01	WT-161
GTR19150284-01	KRAS WT Peptide
GTR19035147-01	Wt hMLN TFA
GTR19185252-01	WT IDH1 Inhibitor 2
GTR19261967-01	EGFR WT/T790M-IN-2

Alternative Products

Catalog	Name
MBS5789743	WT-1 A1
T75173	WT-TTR inhibitor 1
HY-163371	EGFR WT/T790M-IN-1
RP30863-5	WT-1 Peptide (RMFPNAPYL)
PPL50046-4a	PCD513B-1-PPARG (WT)
PPL50086-1	PcDNA3.1-Kcna1 (WT)
PPL01001-2a	PcDNA3.1 (+) -PHEX (WT)
BZ55784	PcDNA3.1-WT-VWF
90026394	Trimethylamine, 33% (wt/wt) in Ethanol
CL-0371	K7M2 wt [K7M2-WT] Cell Line

WT-1 A1

Related Products

Alternative Products

Popular Products